Surge In Weight LossDrugs Could Have Knock-On Effects
Recently, the topic of weight-loss drugs has been extremely popular. Last week, the stock price of Pharmaceutical company Novo Nordisk (NVO) increased by 10% within a week because its weight loss drug Ozempic showed therapeutic effects on chronic kidney failure in diabetic patients during trials.
As public interest in weight loss drugs continues to increase, it may bring some chain reactions to the capital market... Let's take a look at the latest issue of News decoding.
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
Moomoo Learn Official Account
Easy learning at moomoo Learn.
Let's trade smarter！
23KFollowers
105Following
25KVisitors
Follow
Rigid Bull : Novo can't keep up with demand, 1 in 4 people are clinically obese. if millions of people each year are prescribed this medication it will support Novo with increasing profits but destroy demand for unhealthy consumer products such as Coke, Pepsi, Hershey's, Cadbury's we will return to a time before excessive consumption.
Moomoo Learn OP Rigid Bull : Thanks for your generous sharing.